Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • HMorrison
    Senior Member
    • May 2009
    • 121

    Oligo quality issue

    Had 32 primers made that started with "NNNN" at 5' end. I have a full lane of Illumina data reading through these bases and into an inline bar code. I almost always recover the bar code perfectly. I expected to see each base at ~25% in these cycles; instead I get 16%, 17%, 30% and 37% for A, C, G, and T, respectively. That's some pretty sloppy work by the company. I haven't made oligos myself in years, but isn't is just a matter of mixing the four bases in a 5th bottle "N" that goes on the synthesizer?

    Interesting what you learn now that sequencing through oligos as single molecules common. Had a synthesis by a different company (one that is usually highly recommended) where the 3' base was incorrect. They are synthesized from 3' end.
    Attached Files
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    I think some companies offer to "balance" the nucleotides in an "N" base for an additional fee. So I don't think it is just a matter of spiking in the right molar concentration of the reagents.

    That said, seems like many presume that oligo synthesis has far lower (or zero) error rates than it actually has.

    --
    Phillip

    Comment

    • HMorrison
      Senior Member
      • May 2009
      • 121

      #3
      Originally posted by pmiguel View Post
      I think some companies offer to "balance" the nucleotides in an "N" base for an additional fee. So I don't think it is just a matter of spiking in the right molar concentration of the reagents.

      That said, seems like many presume that oligo synthesis has far lower (or zero) error rates than it actually has.

      --
      Phillip
      This company says "Mixed Bases* Degenerate bases. Equal amounts of the designated bases are delivered by the synthesizer.
      A+C+G+T N"

      If a company charged extra for "balancing", I would shop elsewhere. I don't expect perfection, but this is way off the mark. On average, I want the population to reflect what I've ordered. I don't think that is unreasonable or naive.

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Originally posted by HMorrison View Post
        This company says "Mixed Bases* Degenerate bases. Equal amounts of the designated bases are delivered by the synthesizer.
        A+C+G+T N"

        If a company charged extra for "balancing", I would shop elsewhere. I don't expect perfection, but this is way off the mark. On average, I want the population to reflect what I've ordered. I don't think that is unreasonable or naive.
        Many things are easier said than done. If I really needed a balanced N oligo, I would probably take the fact that a company is charging more for it as a sign that they realize there is an issue.

        But, you may be right. Maybe you just got a "Monday" batch of oligos.

        --
        Phillip

        Comment

        • HMorrison
          Senior Member
          • May 2009
          • 121

          #5
          Originally posted by pmiguel View Post
          Many things are easier said than done. If I really needed a balanced N oligo, I would probably take the fact that a company is charging more for it as a sign that they realize there is an issue.

          But, you may be right. Maybe you just got a "Monday" batch of oligos.

          --
          Phillip
          Not sure what company you use. I find that option on the IDT site, although they still offer the vanilla mixed base options using IUPAC codes. I then had a chat with one of the IDT staff. The costs for hand mixed reagents are high. Machine mixing is known to be biased: "Actual reactivity favors T>G>C>A (30%:26%:24%:20%)" and differential flow rates can skew it further. It has been a good day for learning new ways to bias your PCR and sequencing results! Guess the days of the 5th bottle are over (makes sense, now that I think about it more carefullly).

          Comment

          • pmiguel
            Senior Member
            • Aug 2008
            • 2328

            #6
            Originally posted by HMorrison View Post
            Not sure what company you use. I find that option on the IDT site, although they still offer the vanilla mixed base options using IUPAC codes. I then had a chat with one of the IDT staff. The costs for hand mixed reagents are high. Machine mixing is known to be biased: "Actual reactivity favors T>G>C>A (30%:26%:24%:20%)" and differential flow rates can skew it further.
            Maddening, isn't it? And your results do suggest higher skews than those.

            It was one of our customers attempting to use Sanger sequencing chromats to assay the effects of a molecular evolution study who mentioned the availability of higher cost "balanced" N oligos.

            --
            Phillip

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            32 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            43 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            29 views
            0 reactions
            Last Post SEQadmin2  
            Working...